trending Market Intelligence /marketintelligence/en/news-insights/trending/ye_n6chlwryiducy0ryf_a2 content esgSubNav
In This List

AmpliPhi Biosciences closes $3M direct offering

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


AmpliPhi Biosciences closes $3M direct offering

AmpliPhi Biosciences Corp. closed its previously announced registered direct offering for gross proceeds of about $3 million.

The San Diego-based developer of therapies for antibiotic-resistant infections sold 2,743,640 common shares at $1.10 per share as part of the offering.

Net proceeds will go toward general corporate purposes, including expenses for manufacturing, clinical trials and research and development.

H.C. Wainwright & Co. was the exclusive placement agent for the offering.